Literature DB >> 33581853

Recurrent pregnancy losses, a lasting cause of infertility.

Dominique de Ziegler1, Rene F Frydman2.   

Abstract

Recurrent pregnancy loss (RPL), defined as two to three spontaneous pregnancy terminations occurring before 12 weeks of gestation, affects approximately 1% of the general population. The causes may include congenital factors that originate with the quality of the gametes (sperm or oocyte) or the resulting embryo, or factors that originate within the uterus. Alterations of endometrial receptivity from endometriosis and/or endometritis, which are associated with impaired action of progesterone, have also been implicated in RPL. Finally, immunologic factors and thrombophilia, congenital and acquired, have also been suspected to cause RPL.
Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Miscarriage, pregnancy loss, recurrent pregnancy loss, RPL

Mesh:

Year:  2021        PMID: 33581853     DOI: 10.1016/j.fertnstert.2020.12.004

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Maternal Thrombophilic and Hypofibrinolytic Genetic Variants in Idiopathic Recurrent Pregnancy Loss: a Continuing Mystery.

Authors:  Mahmoud Younis; Mohamed A M Ali; Doaa A Ghareeb; Rehab Youssef; Shadia A Fathy
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

2.  Inhibition of HMGB1 Ameliorates the Maternal-Fetal Interface Destruction in Unexplained Recurrent Spontaneous Abortion by Suppressing Pyroptosis Activation.

Authors:  Damin Zhu; Huijuan Zou; Jinxian Liu; Jing Wang; Cong Ma; Jiaqian Yin; Xiaoqing Peng; Danyang Li; Yulu Yang; Yu Ren; Zhiguo Zhang; Ping Zhou; Xiangyan Wang; Yunxia Cao; Xiaofeng Xu
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

3.  Novel approaches to the management of recurrent pregnancy loss: The OPTIMUM (OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu) treatment strategy.

Authors:  Keiji Kuroda; Yuko Ikemoto; Takashi Horikawa; Azusa Moriyama; Yuko Ojiro; Satoru Takamizawa; Toyoyoshi Uchida; Shuko Nojiri; Koji Nakagawa; Rikikazu Sugiyama
Journal:  Reprod Med Biol       Date:  2021-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.